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tier0 at peak exercise. PkVOP correlated with percent change in heart rate after anaero- 
bic threshold in groups A (rxO.45, p=O.O07) and Bn (r=O.67, p<O.OOl) only. 
Conclusions: P1s with resting LVOTO have poorer indices of cardiac function/exercise 
capacity. Non-obstructive HCM pts with exercise-induced LVOTO have cardiopulmonary 
indices consistent with better stroke volume augmentation during exercise. 
Table 1. Comparison of exsrcise parameters between the three groups. 
1015-162 Prediction of Sudden Death in Patlents With Dilated 
Cardiomyopathy Receiving Angiotensin Converting 
Enzyme Inhibitors and Beta-Blockers: The Extent of 
intercellular Myocardial Fibrosis and the Presence of 
Nonsustained Ventricular Tachycardia 
March 6,2002 
Takahisa Yamada. Masatake Fukunami. Tsuyoshi Shimonagata, Kazuaki Kumagai, Akio 
Hirata, Mitsutoshi Asai, Nobuhiko Makim, Hidetaka Kioka, Noritake Hoki, Osaka 
Prefectural General Hospital, Osaka, Japan. 
Background: Recent clinical trials have shown that angiotensin-converting enzyme 
inhibitors (ACEI) and beta-blockers (BE) reduce the mortality in patients with dilated car- 
diomyopathy (DCM). However, some DCM patients still died suddenly in spite of the 
administration of ACEI and BB. We tried lo identify patients at risk for sudden death in 
DCM patients receiving ACEI and BB. Methods: We studied 50 DCM patients (NYHA 
class: 2.6M.6, left ventricular ejection fraction: 32+6%) receiving ACEI (76%) and BB 
(76%). At the baseline, we performed echocardiography, 24 hour Halter monitoring, right 
side cardiac catheterization, left ventricular endomyocardlel biopsy. The extent of myo- 
cardial fibrosis was estimated by the point count method in all biopsy samples. Moreover, 
after classifying myocardial fibrosis separately into two types, intercellular (IC) and inter- 
fascicular fibrosis, by the distribution of fibrosis on each cross point, we also estimated 
the extent of each fibrosis. 
Results: During the observation period of 56ti6 months, 8 patients died suddenly. By 
multivariate Cox analysis, out of the variables including clinical, hemodynamic. echocar- 
diographic parameters, the presence of nonsustained ventricular tachycardia (VT: more 
than 5 consecutive ventricular ectopic beats) and the extent of myocardial fibrosis, the 
extent of IC fibrosis (p=O.O05) and the presence of nonsustained VT (p=O.O4) were inde- 
pendently associated with sudden death. Kaplan-Meier analysis revealed that patients 
with a greater extent of IC fibrosis (~-12.5%) and nonsustained VT (Group I) showed sig- 
nificantly higher rate of sudden death than those with a lesser extent of IC fibrosis or the 
absence of nonsustained VT (Group II) (67% vs 9%, p<O.OOOl). 
Conclusion: The extent of IC fibrosis and the presence of nonsustained VT would be a 
powerful predictive marker for sudden death in DCM patients receiving ACEI and 99. 
Peak Workload 
pkVO2 
pk02 pulse 
atVO2 
at02 pulse 
GROUP A p(A v Bi) GROUP Bi p(Bi v Bn) GROUP Bn 
62 zt23 <O.OOl 67 +21 0.003 67+19 
65 +I9 <0.001 65*16 0.002 66 +I7 
62 +I9 0.003 99*18 0.004 62 +I9 
35~12 0.007 44 *I3 “s 39 *9 
59 *20 0.006 74 *I8 “S 64215 
1015160 Quantification of Myocardial Injury After Percutaneous 
Transluminal Septal Myocardial Ablation in 
Hypertrophlc Obstructive Cardiomyopathy 
m, Folkerl J. ten Cab?, Jurrien M. ten Berg, Aernout M. Beck, Albert 
C. van Rossum, VU University Medical Center, Amsterdam, The Netherlands. 
Background: Percutaneous transluminal septal myocardial ablation (PTSMA) is a non- 
surgical therapeutic procedure for reducing len ventricular outflow tract obstruction in 
symptomatic patients with hyperlrophic obstructive cardiomyopathy (HOCM). The aim of 
this study was to evaiuale septal myocardial injury size aner PTSMA using delayed con- 
trast-enhanced (DCE) magnetic rssonancs imaging (MRI). 
Methods: 12 patients (mean age 52*15 years, 7 males) underwent MRI before and 4 
weeks after PTSMA: volume of ethanol injected during procedure was 1 to 5 mL. Images 
were acquired on a 1.5 T scanner (Vision/Sonata, Siemens, Erlangen. Germany). Cine 
gradient-echo MRI was performed for assessment of global I& ventricular function at 
baseline and follow-up. Inversion-recovery turbo-FLASH images (TE 3.4 ms. TR 7.6 ms, 
TI 250-300 ms) were acquired at follow-up, 20 to 30 minutes after i.v. administration of 
0.2 mmolikg gadolinium-DTPA. Left ventricular function parameters, myocardial mass, 
and hyperenhanced area’s (including central dark zones of hypoenhancement) were 
quantified using the MASS software package (Leiden University Medical Center, the 
Netherlands). 
Results: Lefl ventricular mass values before and after PTSMA were 235.6 * 70.7 g vs. 
225.2 * 71.7 g (p=O.OOl), respectively. Septal myocardial mass pre- and post PTSMA 
were 79.2 * 29.4 g vs. 72.7 * 26.2, resp. In all patients the injured myocardium was well 
visualized. The hyperenhanced septal myocardial mass was in the range of 3.6 to 24.9 g 
[mean: 12.6 * 7.6 g], and involved 5.0 % f 4.0 of the post-ablational total LV mass vs. 
21.2 % * 16.0 of the septal myocardial mass. Myocardial injury size was not correlated 
with the volume of ethanol administered. 
Conclusions: The extent of myocardial injury after PTSMA can be determined using 
DCE-MRI and was not correlated with the volume of ethanol administered. The method 
may serve as control and feedback for the interventional procedure. 
1015-161 Untoward Effect of Septal Reduction Interventions on 
Conduction System in Patients With Obstructive 
Hypertrophic Cardiomyopathy 
,!ian Xin Qin, Takahiro Shiota, Harry M. Lever, Neil L. Greenberg, Deborah A. Agler, 
Jeanne K. Drinko, Maureen Martin, Maura J. Schnauffer, Nicholas G. Smedira, E. Murat 
Tuzcu, Bruce Lytle. James D. Thomas, The C/eve/and Clinic Foundation, Cleveland, 
Ohio. 
Hypertrophic obstructive cardiomyopathy (HOCM) patients may develop conduction 
abnormalities after percutaneous transluminal septal myocardial ablation (PTSMA) and 
myectomy (MYE) procedures. The aim of the study was to observe the impact of both 
procedures on the conduction system. Methods: A total of 101 HOCM patients without 
preexisting permanent pacemaker were enrolled in this study. 55 patients were included 
in MYE and 46 patients in PTSMA group. Standard 12 leads ECGs were acquired before 
and 3-month after the procedures. Doppler echo was used to quantify the LVOT pressure 
gradient (PG). Results: Both PTSMA and MYE significantly reduced the LVOT PG (66 f 
41 vs 29 ? 26 mmHg for PTSMA and 66 * 44 YS 14 f IO mmHg for MYE, both p < 
0.0001). Aner PTSMA, a permanent pacemaker was implanted in 13 (26%) patients. 20 
patients developed new complete right bundle branch block (CRBBB). After MYE, 6 
(11%) patients required permanent pacemakers (p-=0.05 vs PTBMA) while 36 patients 
developed complete left bundle branch block (CLBBB) (table). 
N Pacer CRBBB CLBBB 
Pre Post Prs POSt 
PTSMA 46 13 (26%) 3 (7%) 23 (70%) 0 (0%) 2 (2%) 
MYE 55 6 (11%)’ 0 (0%) 0 (O%)T 3 (5%) 41 (64%)t 
MYE vs PTSMA, * p-z 0.05, t p < 0.0001. 
5 PTSMA patients required subsequent myectomy because of incomplete relief of the 
PG. 4 of them needed permanent pacemakers. Conclusion: Both F’TSMA and MYE sig- 
nificantly reduced LVOT PG. However, right branch bundle block was frequently pro- 
duced by PTSMA and left branch bundle block was often caused by MYE. Severe AV 
block may develop when both procedures are required. 
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1016-141 QT Dispersion Is Not Associated With Left Ventricular 
Function in Elderly Patients With Symptomatic Heart 
Failure: ELITE II Substudy 
Y~_G~QQ, Takuya One, Katerina Hnatkova, Kenich Hashimoto, A. John Camm, Berlram 
Pin, Philip A. Poole-Wilson, Frederic Sax, Kathryn Bohannon. Marek Malik. for ELITE II 
investigators, St. George’s Hospital Medical School, London, United Kingdom, Merck 
Research Laboratories, West Point, Pennsylvania. 
Background It remains controversial if QT dispersion (QTd) is associated with left ventric- 
ular function or aetiology in patients (pts) with hearl failure (HF). 
Methods To examine the &.ociation behveen QTd and left ventricular function and the 
prognostic value of QTd in HF secondary either to idiopathic dilated cardiomyopathy 
(IDC) or ischaemic heari disease (IHD), we studied 966 HF pts (age 71?7 year, 703 men) 
enrolled into the ELITE II trial. Of study pts, 766 had IHD (age 71i7 years, 573 men) and 
105 had IDC (age 7lt7 years, 65 men). QT intervals were manually measured on stan- 
dard IP-lead ECGs using an in-house computer assisted system. 
Results In all study pts, the mean QTd and JTd were 66i31 and 62i32 ms, respectively. 
In pts with LVEF<25%, heart rare was significantly higher (PcO.0001) and QT was signif- 
icantly shorter (~25% (66+31 Y 66i31 ms). No significant difference in QTd was found 
between pts with and without NYHA class III-IV either (67i31 Y 64f32 ms). QTd was not 
correlated with LVEF (r= -0.0004) or NYHA (r= -0.04). During follow-up (54til53 days), 
119 (12%) pts died of cardiac cause (CD), including 59 (6%) sudden death (SD). A pro- 
spective cut-off value at QTd>60 ms failed to identify pts with CD or SD, while signifi- 
cantly more patients with LVEF<25% died of CD than those with LVEF>25% (16% v II%, 
p=O.O45). There were no significant differences in age and NYHA functional class 
between IHD and IDC. More male (75% v 62%. p=O.OOS) and higher LVEF (31.6k6.6 v 
26.2+7.1%, p<O.OOl) were found in IHD than IDC. The mean QTd in IHD were similar to 
IDC (66+32 v 67i27 ms) and it was not related to mortality at all. The frequency of CD or 
SCD were not significantly different in IDC and IHD (II%, 6% v 13%, 6%, respectively, 
p=NS). In both IHD and IDC, a QTd >60ms failed to predict CD or SCD. The results 
remained unchanged when JTd was analysed in the same manner. 
Conclusions In this ELITE II substudy, QTd (and JTd) was neither associated with len 
ventricular function. nor with aetiology of heart failure. Reduced LVEF remains a slgnifi- 
cant predictor of CD but increased QTd did not predict mortality irrespective of aetlology 
of HF. 
